|
ZNF416 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.261200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16840000000418E-05 |
| Normal-vs-Stage2 |
1.820210E-01 |
| Normal-vs-Stage3 |
7.254100E-02 |
| Normal-vs-Stage4 |
3.744700E-03 |
| Stage1-vs-Stage2 |
8.47170000000119E-05 |
| Stage1-vs-Stage3 |
5.91810000005744E-07 |
| Stage1-vs-Stage4 |
2.00380001480482E-09 |
| Stage2-vs-Stage3 |
7.037400E-01 |
| Stage2-vs-Stage4 |
2.460000E-01 |
| Stage3-vs-Stage4 |
4.447800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.536000E-01 |
| Normal-vs-AfricanAmerican |
8.428000E-01 |
| Normal-vs-Asian |
8.263200E-01 |
| Caucasian-vs-AfricanAmerican |
8.337800E-01 |
| Caucasian-vs-Asian |
9.402200E-01 |
| AfricanAmerican-vs-Asian |
8.875400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.901400E-01 |
| Normal-vs-Female |
1.031960E-01 |
| Male-vs-Female |
1.095190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.906000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.622560E-01 |
| Normal-vs-Age(61-80Yrs) |
9.823400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.026400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.448400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.679400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.552420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.345770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.090000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.284200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.600900E-04 |
| Normal-vs-Grade 2 |
4.14420000000026E-05 |
| Normal-vs-Grade 3 |
2.253400E-01 |
| Normal-vs-Grade 4 |
1.66973999999875E-05 |
| Grade 1-vs-Grade 2 |
4.507400E-01 |
| Grade 1-vs-Grade 3 |
8.158200E-04 |
| Grade 1-vs-Grade 4 |
3.73480000004367E-06 |
| Grade 2-vs-Grade 3 |
8.96640000025428E-08 |
| Grade 2-vs-Grade 4 |
2.23088214568179E-12 |
| Grade 3-vs-Grade 4 |
7.762700E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.89425000000076E-05 |
| Normal-vs-ccB subtype |
2.495400E-01 |
| ccA subtype-vs-ccB subtype |
9.89060000011754E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.243000E-01 |
| Normal-vs-N1 |
4.701600E-02 |
| N0-vs-N1 |
5.487700E-02 |
|
|
